1 | Advances in Stem Cell Therapies (SLE – Page 4) |
2 | Anti-Ab Drug Screening Platform Using Human iPS Cell- Derived Neurons for the Treatment of Alzheimer’s Disease |
3 | Application of induced pluripotent stem cells for cartilage regeneration |
4 | Application of induced pluripotent stem cells to primary immunodeficiency diseases |
5 | Use of Induced Pluripotent Stem Cells in Dermatological Research |
6 | Autologous Induced Stem-Cell Derived Retinal Cells for Macular Degeneration |
7 | Building a micro physiological skin model from iPSCs |
8 | Cardiac regeneration using HLA-matched induced pluripotent stem cells |
9 | Cell Therapy Applications for Retinal Vascular Diseases-Diabetic Retinopathy |
10 | Cell therapy for intervertebral disc repair-Clinical perspective |
11 | Cell-Based Therapies Used to Treat Lumbar Degenerative Disc Disease |
12 | Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells |
13 | Endothelial Lineage Differentiation from Induced Pluripotent Stem Cells |
14 | Establishment of a complex skin structure derived from iPSCs |
15 | Exosomes Derived from iPSCs Ameliorate the Aging of Skin Fibroblasts |
16 | From skin to the treatment of diseases û the possibilities of iPS cell research in dermatology |
17 | Functional Thyroid Follicular cells Differentiation from induced Pluripotent stem cells |
18 | Generation of Melanocytes from Induced Pluripotent Stem Cells |
19 | Generation of pancreatic beta cells for treatment of diabetes |
20 | Generation of thyroid follicular cells from pluripotent stem cells potential for regenerative medicine |
21 | Immunosuppression by MSC |
22 | Implications for a Stem Cell Regenerative Medicine Based Approach to Human Intervertebral Disk Degeneration |
23 | Important advances in AlzheimerÆs disease from the use of iPSCs |
24 | In vivo repair of full thickness cartilage defect with human iPSC derived mesenchymal progenitor cells |
25 | Induced pluripotent and mesenchymal stem cells as a promising tool for articular cartilage regeneration |
26 | Induced pluripotent stem cell-derived MSC activate quiescsnt T cells and elevate regulatory T cell response |
27 | Induced Pluripotent Stem Cells for Lung Regeneration |
28 | Induced Pluripotent Stem Cells Improve Stroke Outcome and Reduce Secondary Degeneration in the Recipient Brain |
29 | Induced pluripotent stem cells in AlzheimerÆs disease – applications for cell-replacement therapy |
30 | Induced pluripotent stem cells in cartilage repair |
31 | Induced Pluripotent Stem Cells in Dermatology-Potentials, Advances |
32 | Induced pluripotent stem cells in Parkinson’s disease |
33 | iPSC for Therapeutic Approaches to the Nervous System |
34 | iPSCs Alleviates Cerebral Inflammation and Neural Damage in Hemorrhagic Stroke |
35 | iPSCs derived neural progenitors increases regeneration and functional recovery after ischemic stroke |
36 | Neuronal differentiation of self-renewing neural progenitor cell lines obtained from iPSCs |
37 | Neuroplacement and Stem Cell Biology |
38 | Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung versus thyroid lineage specification |
39 | Pluripotent stem cell technology – a promising remedy for hypopigmentation disorders |
40 | Pluripotent stem cells-the last 10 years |
41 | Potential Applications for Using Stem Cells in Spine Surgery |
42 | Potential of Stem Cell-Based Therapy for Ischemic Stroke |
43 | Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell Therapy |
44 | Promise of Human Induced Pluripotent Stem Cells in Skin Regeneration |
45 | Regeneration of Thyroid Function by Transplantation of Differentiated Pluripotent Stem Cells |
46 | Regenerative iPSCs Therapy for Hypothyroidism |
47 | Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization |
48 | Stem cell therapies in the treatment of diabetic retinopathy |
49 | Stem Cell Therapy for Alzheimer’s Disease |
50 | Stem Cell-Based Therapies for Ischemic Stroke |
51 | Stem Cells Applications in Regenerative Medicine (SLE – Page 2) |
52 | Stem cells sources for intervertebral disc regeneration |
53 | The Application of Human iPSCs in Neurological Diseases |
54 | The Future of Stem Cell Therapy in Retina |
55 | The Future Roles for iPSCs Therapy for auto-immune diseases |
56 | Therapeutic Potential Induced Pluripotent Stem Cells in Stroke |
57 | Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells |
58 | Direct in vivo application of induced pluripotent stem cells is feasible |
59 | Differentiation Potential of Induced Pluripotent Stem Cells (iPSCs) to Nucleus Pulposus Cells in Vitro |
60 | Differentiation of iPSCs into functional podocytes |
61 | Current Methods for Skeletal Muscle Tissue Repair and Regeneration |
62 | Considerations in hiPSC-derived cartilage for articular cartilage repair |
63 | CHONDROGENIC DIFFERENTIATION OF iPSCs FROM OSTEOARTHRITIC CHONDROCYTES IN ALGINATE MATRIX |
64 | Center for Developmental Biology (CDB)-Making Skin from iPSCs |
65 | Treating neurodegenerative disease with iPSCs |
66 | Treatment of multiple sclerosis by transplantation of iPSCs |
67 | Thyroid cell differentiation from induced pluripotent stem cells |
68 | Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells |
69 | The potential of induced pluripotent stem cells in models of neurological disorders |
70 | Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury |
71 | Therapeutic Translation of iPSCs for Treating Neurological Disease |
72 | Seamless gene correction of b-thalassemia mutations in patient-specific iPSCs |
73 | Solving the puzzle of Parkinson’s disease using iPSCs |
74 | Stem Cell-Based Therapies for Multiple Sclerosis |
75 | Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells |
76 | Induced Pluripotent Stem Cells Past, Present, and Future |
77 | Induced pluripotent stem cellûderived hepatocytes have the functional and proliferative capabilities needed for liver regeneration |
78 | Induced pluripotent stem-cellûderived neurospheres promote motor functional recovery after spinal cord injury |
79 | Induced stem cells as a novel multiple sclerosis therapy |
80 | Induction of pluripotency by defined factors |
81 | iPS cells a game changer for future medicine |
82 | Making Steady Progress on Direct Cardiac Reprogramming Toward Clinical Application |
83 | Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis |
84 | Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells |
85 | Multiple sclerosis- getting personal with iPSCs |
86 | Myocardium Derived from Induced Pluripotent Stem Cells Improves Cardiac Function |
87 | Perspectives for Induced Pluripotent Stem Cell Technology |
88 | Human Induced Pluripotent Stem CellûDerived Ectodermal Precursor Cells Contribute to Hair Follicle Morphogenesis In Vivo |
89 | Immunogenicity of Induced Pluripotent Stem Cells |
90 | Induced pluripotent stem cell tech for therapy of cerebellar ataxia |
91 | Induced pluripotent stem cell-derived MSC activate quiescsnt T cells and elevate regulatory T cell response |
92 | Induced pluripotent stem cells for adoptive cellular immunotherapy |
93 | Induced Pluripotent Stem Cells For Cardiac Applications |
94 | Induced pluripotent stem cells in medicine and biology |
95 | Induced pluripotent stem cells opportunities and challenges |
96 | Human Induced Pluripotent Stem CellûDerived Ectodermal Precursor Cells Contribute to Hair Follicle Morphogenesis In Vivo |
97 | Immunogenicity of Induced Pluripotent Stem Cells |
98 | Induced pluripotent stem cell tech for therapy of cerebellar ataxia |
99 | Induced pluripotent stem cell-derived MSC activate quiescsnt T cells and elevate regulatory T cell response |
100 | Induced pluripotent stem cells for adoptive cellular immunotherapy |
101 | Induced Pluripotent Stem Cells For Cardiac Applications |
102 | Induced pluripotent stem cells in medicine and biology |
103 | Induced pluripotent stem cells opportunities and challenges |
104 | Human Induced Pluripotent Stem CellûDerived Ectodermal Precursor Cells Contribute to Hair Follicle Morphogenesis In Vivo |
105 | Immunogenicity of Induced Pluripotent Stem Cells |
106 | Induced pluripotent stem cell tech for therapy of cerebellar ataxia |
107 | Induced pluripotent stem cell-derived MSC activate quiescsnt T cells and elevate regulatory T cell response |
108 | Generation of Human Melanocytes from Induced Pluripotent Stem Cells |
109 | Germline development from pluripotent stem cells toward disease modeling of infertility |
110 | Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia |
111 | Hematopoietic stem cell transplantation in thalassemia major |
112 | Efficient and Rapid Induction of iPSCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods |
113 | Efficient and Scalable Purification of Cardiomyocytes |
114 | Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes |
115 | Epigenetic foundations of pluripotent stem cells that recapitulate in vivo pluripotency |
116 | Regenerative medicine for the kidney – stem cell prospects & challenges |
117 | Cure for thalassemia major û from allogeneic hematopoietic stem cell transplantation |
118 | Development of iPSC technology in Parkinson’s Disease |
119 | Differentiation of Cardiovascular Cells From Induced Pluripotent Stem Cells |
120 | Cell reprogramming and neuronal differentiation applied – Focus on Parkinson’s disease |
121 | Cell Therapy Using Induced Pluripotent Stem Cell Ameliorates Acute Kidney Injury |
122 | Cellular and molecular interactions of mesenchymal stem cells in innate immunity |
123 | Characterization of Dendritic Cells and Macrophages Generated Induced Pluripotent Stem Cells |
124 | Anti-Ab Drug Screening Platform Using Human iPS Cell- Derived Neurons for the Treatment of Alzheimer’s Disease |
125 | Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia |
126 | Autologous Induced Stem-CellûDerived Retinal Cells for Macular Degeneration |
127 | Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes |
128 | A Fresh Look at iPS Cells |
129 | A review on stem cell therapy for multiple sclerosis |
130 | Adipogenic differentiation of induced pluripotent stem cells Comparison with that of embryonic stem cells |
131 | Allogeneic stem cell transplantation for thalassemia major in India |
132 | The prospect of induced pluripotent stem cells for diabetes mellitus treatment |
133 | Stem cells and kidney regeneration |
134 | Stem cell therapies for acute kidney injury |
135 | Regenerative medicine for the kidney – stem cell prospects & challenges |
136 | Progress in Stem Cell Therapy for Diabetic Nephropathy |
137 | iPSCs from Type 1 Diabetic Patients Enhances Differentiation into Functional Pancreatic β-cells |
138 | iPSC derived pancreatic b-like cell differentiation |
139 | Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice |
140 | Induced mesenchymal stem cells for treating chronic renal insufficiency |
141 | iPSC technology-based regenerative therapy for diabetes |
142 | Growing Kidney Tissue from Stem Cells |
143 | Generating kidney tissue from pluripotent stem cells |
144 | Current stem cell based therapies in diabetes |
145 | Cell-based therapy for kidney disease |
146 | Cell replacement therapies to treat type 1 diabetes mellitus |
147 | Cell reprogramming and neuronal differentiation applied – Focus on Parkinson’s disease |
148 | Treating neurodegenerative disease with iPSCs |
149 | Stem Cells as New Agents for the Treatment of Infertility |
150 | Stem cell therapeutic possibilities-male-factor and female-factor infertility |
151 | Solving the puzzle of Parkinson’s disease using iPSCs |
152 | Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells |
153 | Development of iPSC technology in Parkinson’s Disease |
154 | Creation of a library of induced pluripotent stem cells from Parkinson patients |
155 | Cell Therapy Applications for Retinal Vascular Diseases-Diabetic Retinopathy |
156 | Cell-based therapeutics for liver disorders |
157 | Cholesterol-Secreting and Statin-Responsive Hepatocytes from Human ES and iPS Cells |
158 | Development with Pluripotenent Stem Cells and Characterizing the putatuve Oogonial Stem Cells |
159 | Differentiation of Induced Pluripotent Stem Cells into Male Germ Cells through Embryoid Body Formation and Testosterone Induction |
160 | Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency |
161 | Evaluation of Cholesterol Reduction Activity of Methyl-B-cyclodextrin Using iPSC Differentiated Human Neurons |
162 | From Spermatogonial Stem Cell to Spermatids in Mammals |
163 | Functional Neurons Generated from Induced Pluripotent Stem Cells for Neurological Diseasea |
164 | Genetic And Chemical Correction Of Cholesterol Accumulation In Hepatic And Neural Cells Derived From PatientSpecific iPS Cells |
165 | Human germ cell differentiation from induced pluripotent stem cells |
166 | Human iPS Cell-Derived Germ Cells Current Status and Clinical Potential |
167 | Induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. |
168 | Induced Pluripotent Stem Cells How They Will Change the Practice of Cardiovascular Medicine |
169 | iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia. |
170 | Modeling Liver Diseases Using Induced Pluripotent Stem Cell iPSC Derived Hepatocytes |
171 | Pluripotent stem cells the last 10 years |
172 | Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment |
173 | Primordial Germ Cells Current Knowledge and Perspectives |
174 | Recreating the female reproductive tract in vitro using iPSC technology |
175 | Stem Cell in Treatment of Schizophrenia |
176 | Stem cell therapies in the treatment of diabetic retinopathy |
177 | The Future of Stem Cell Therapy in Retina |
178 | Use of Induced Pluripotent Stem Cell-derived Cardiomyocytes As a Screen for Drug-induced Cardiotoxicity |
179 | Molecular and cellular basis of hematopoietic stem cells maintena |
180 | Pluripotent Stem Cells, Endogenous vs Reprogrammed |
181 | Stem Cells (iPSCs) Applications in Regenerative Medicine |
182 | The Future Roles for iPSCs Therapy for auto-immune diseases |
183 | Advances in Stem Cell Therapies |
184 | Induced pluripotent stem cell generation from patients with kidney transplantation |
185 | Induced pluripotent stem cell potential in reproductive medicine |
186 | Induced pluripotent stem cells in the study of neurological diseases |
187 | Applications of Patient-Specific Induced Pluripotent Stem Cells |
188 | Clinical Therapy Using iPSCs Hopes and Challenges |
189 | Efficient Generation of Human iPSCs |
190 | Efficient generation of transgene-free induced pluripotent stem cells (iPSCs) |
191 | Endothelial Lineage Differentiation from Induced Pluripotent Stem Cells |
192 | GABAergic and glycinergic IPSCs in Ganglion Cells |
193 | Generation of Functional Cardiomyocytes from Efficiently Generated iPSCs |
194 | Generation of human iPSCs from cells of fibroblast and epithelial origns |
195 | Impact of Nanotechnology in iPSCs driven Regenerative Medicine |
196 | Induced pluripotent stem cell tech for therapy of cerebellar ataxia |
197 | Induced Pluripotent Stem Cells for Post-Myocardial Infarction Repair |
198 | Induced pluripotent stem cells in ParkinsonÆs disease |
199 | iPSCs – applications in regenerative medicine |
200 | iPSCs and neurological disease modeling – progress and promises |
201 | iPSCs quick facts |
202 | Large scale generation of iPSC derived neural stem cells early progenitor cells and their differentiation |
203 | Mechanism of Induction- Induced Pluripotent Stem Cells (iPSCs) |
204 | Modeling Alzheimer’s Disease with iPSCs |
205 | Modeling Liver Diseases Using Induced Pluripotent Stem Cell (iPSCs) – derived Hepatocytes |
206 | Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell Therapy |
207 | Successful human intestinal organs derived from iPSCs |
208 | The Application of Human iPSCs in Neurological Diseases |
209 | The Emerging Potential and Perspectives of Induced Pluripotent Stem Cells (iPSCs) |
| | |
1 | Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA (ppt file) |
2 | Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes (ppt file) |
